Ethacrynic acid is a medication used in the management and treatment of chronic heart failure. It is in the loop diuretic class of drugs. This activity describes the indications, action, and contraindications for ethacrynic acid as a valuable agent in managing fluid overload and CHF. This activity will highlight the mechanism of action, adverse event profile, and other key factors (e.g., off-label uses, dosing, pharmacodynamics, pharmacokinetics, monitoring, relevant interactions) pertinent for members of the healthcare team in the management of patients with CHF and related conditions.

**Objectives:**
- Explain the treatment considerations for patients with chronic heart failure and a sulfa allergy.
- Describe the adverse effects and contraindications of ethacrynic acid.
- Review the appropriate monitoring for patients on ethacrynic acid therapy.
- Outline some interprofessional team strategies for improving care coordination and communication to advance ethacrynic acid and improve outcomes.